Viewing StudyNCT03610516



Ignite Creation Date: 2024-05-06 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03610516
Status: COMPLETED
Last Update Posted: 2023-07-28
First Post: 2018-06-01

Brief Title: Safety Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Lupus Nephritis
Keywords:
Name View
anti-CD40 View
CFZ533 View
moderately active lupus nephritis View